Amg National Trust Bank Amgen Inc Transaction History

Amg National Trust Bank

$3.7 Billion
Q3 2024

A detailed history of Amg National Trust Bank transactions in Amgen Inc stock. As of the latest transaction made, Amg National Trust Bank holds 10,157 shares of AMGN stock, worth $2.84 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

10,157

Previous 26,259 61.32%

Holding current value

$2.84 Million

Previous $8.2 Million 60.12%

% of portfolio

0.09%

Previous 0.22%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$309.38 - $337.38 $4.98 Million - $5.43 Million	-16,102 Reduced 61.32%	10,157 $3.27 Million
Q2 2024 Jul 25, 2024	SELL	$262.75 - $319.31 $863,922 - $1.05 Million	-3,288 Reduced 11.13%	26,259 $8.2 Million
Q1 2024 May 06, 2024	SELL	$268.87 - $324.56 $54,311 - $65,561	-202 Reduced 0.68%	29,547 $8.4 Million
Q4 2023 Feb 08, 2024	BUY	$255.7 - $288.46 $12,273 - $13,846	48 Added 0.16%	29,749 $8.57 Million
Q3 2023 Nov 08, 2023	SELL	$218.65 - $271.46 $49,852 - $61,892	-228 Reduced 0.76%	29,701 $7.98 Million
Q2 2023 Aug 02, 2023	BUY	$214.27 - $253.37 $295,478 - $349,397	1,379 Added 4.83%	29,929 $6.64 Million
Q1 2023 May 10, 2023	BUY	$225.79 - $275.2 $4.42 Million - $5.39 Million	19,579 Added 218.25%	28,550 $6.9 Million
Q4 2022 Feb 07, 2023	SELL	$229.03 - $291.01 $779,389 - $990,307	-3,403 Reduced 27.5%	8,971 $2.36 Million
Q3 2022 Nov 03, 2022	BUY	$224.46 - $253.15 $764,510 - $862,228	3,406 Added 37.98%	12,374 $2.79 Million
Q2 2022 Aug 05, 2022	SELL	$230.71 - $256.74 $59,984 - $66,752	-260 Reduced 2.82%	8,968 $2.21 Million
Q1 2022 May 10, 2022	SELL	$219.27 - $242.57 $213,788 - $236,505	-975 Reduced 9.56%	9,228 $2.23 Million
Q4 2021 Feb 04, 2022	BUY	$198.88 - $227.6 $88,899 - $101,737	447 Added 4.58%	10,203 $2.3 Million
Q3 2021 Oct 28, 2021	SELL	$212.27 - $248.7 $86,606 - $101,469	-408 Reduced 4.01%	9,756 $2.08 Million
Q2 2021 Aug 03, 2021	SELL	$233.58 - $259.14 $224,703 - $249,292	-962 Reduced 8.65%	10,164 $2.48 Million
Q1 2021 May 11, 2021	BUY	$221.91 - $258.6 $105,629 - $123,093	476 Added 4.47%	11,126 $2.77 Million
Q4 2020 Feb 10, 2021	BUY	$216.38 - $257.67 $288,001 - $342,958	1,331 Added 14.28%	10,650 $2.45 Million
Q4 2020 Jan 29, 2021	SELL	$216.38 - $257.67 $143,676 - $171,092	-664 Reduced 6.65%	9,319 $2.14 Million
Q3 2020 Oct 22, 2020	SELL	$234.65 - $260.95 $34,024 - $37,837	-145 Reduced 1.43%	9,983 $2.54 Million
Q2 2020 Aug 13, 2020	BUY	$197.81 - $242.74 $1.75 Million - $2.14 Million	8,831 Added 680.88%	10,128 $2.39 Million
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $71,073 - $94,263	-390 Reduced 23.12%	1,297 $262,000
Q4 2019 Feb 04, 2020	BUY	$189.21 - $243.2 $54,870 - $70,528	290 Added 20.76%	1,687 $406,000
Q3 2019 Nov 05, 2019	BUY	$174.11 - $208.62 $17,411 - $20,862	100 Added 7.71%	1,397 $270,000
Q2 2019 Jul 31, 2019	SELL	$166.7 - $195.41 $2 Million - $2.35 Million	-12,016 Reduced 90.26%	1,297 $0
Q1 2019 Apr 25, 2019	SELL	$180.87 - $203.88 $104,000 - $117,231	-575 Reduced 4.14%	13,313 $0
Q4 2018 Feb 12, 2019	SELL	$178.4 - $208.25 $10,704 - $12,495	-60 Reduced 0.43%	13,888 $2.7 Million
Q3 2018 Oct 24, 2018	SELL	$185.29 - $208.89 $12,414 - $13,995	-67 Reduced 0.48%	13,948 $0
Q2 2018 Jul 18, 2018	SELL	$166.05 - $186.51 $172,692 - $193,970	-1,040 Reduced 6.91%	14,015 $0
Q1 2018 Apr 16, 2018	BUY	$169.43 - $198.0 $121,820 - $142,362	719 Added 5.02%	15,055 $0
Q4 2017 Feb 08, 2018	SELL	$168.79 - $188.59 $7,089 - $7,920	-42 Reduced 0.29%	14,336 $0
Q3 2017 Nov 02, 2017	SELL	$167.29 - $191.0 $41,989 - $47,941	-251 Reduced 1.72%	14,378 $0
Q2 2017 Aug 10, 2017	BUY	N/A	14,629	14,629 $0

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amg National Trust Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amg National Trust Bank with notifications on news.

Account

Amg National Trust Bank Amgen Inc Transaction History